The research of the Gynecologic Oncology Research Group  at the Perlmutter Cancer Center encompasses both clinical and translational efforts that are designed to link patient management with advances in our understanding of the processes that lead to malignancy. The focus of our work includes both premalignant, borderline, and malignant tumors that arise in the female reproductive system, as well as gestational trophoblastic disease and any malignancies that complicate pregnancy.
Members of the Gynecologic Oncology Research Group  have held key roles in national organizations devoted to this field, including the Society of Gynecologic Oncology and the Gynecologic Oncology Group (GOG), and in national clinical trial organizations. Researchers at the Perlmutter Cancer Center have chaired the medical oncology committee of GOG, and several of our physicians have been members of the ovarian and endometrial committees of GOG.
The Perlmutter Cancer Center’s Gynecologic Oncology Research Group works to understand and treat gynecologic cancers. Gynecologic cancers include tumors that arise in the ovaries, Fallopian tubes, peritoneum, uterus, cervix, vagina, and vulva of women. The aim of our research is to gain a better understanding of the cancers of the female reproductive system in order to prevent and treat them.
The group accomplishes this through basic laboratory research and translational clinical trials that bring the knowledge gained in the laboratory into the clinical setting to improve the care of our patients. We give our patients access to cutting edge clinical trials through our experienced and nationally prominent multidisciplinary team.
Gynecologic Oncology Research Group members includes:
- Gynecologic oncologists
- Medical oncologists dedicated to the care of patients with gynecologic cancer
- Radiation oncologists
- Gynecologic pathologists
- Radiologists, including interventional radiologists and specialists in gynecologic PET and MRI imaging, and ultrasonography
- Translational scientists